Two Sigma Investments, LP Mei Pharma, Inc. Transaction History

Two Sigma Investments, LP

$41.1 Billion
Q2 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.21 - $0.35 $10,400 - $17,334	49,526 Added 26.86%	233,931 $53,000
Q4 2022 Feb 14, 2023	SELL	$0.22 - $8.4 $42,813 - $1.63 Million	-194,606 Reduced 51.35%	184,405 $44,000
Q3 2022 Nov 14, 2022	BUY	$0.41 - $8.8 $52,088 - $1.12 Million	127,046 Added 50.42%	379,011 $147,000
Q2 2022 Aug 15, 2022	SELL	$0.42 - $0.65 $208,939 - $323,358	-497,475 Reduced 66.38%	251,965 $152,000
Q1 2022 May 16, 2022	BUY	$0.54 - $2.74 $354,303 - $1.8 Million	656,117 Added 703.06%	749,440 $452,000
Q4 2021 Feb 14, 2022	BUY	$2.33 - $3.37 $130,978 - $189,441	56,214 Added 151.48%	93,323 $249,000
Q3 2021 Nov 15, 2021	BUY	$2.52 - $2.99 $25,588 - $30,360	10,154 Added 37.67%	37,109 $102,000
Q2 2021 Aug 16, 2021	SELL	$2.6 - $3.65 $1.68 Million - $2.36 Million	-646,733 Reduced 96.0%	26,955 $77,000
Q1 2021 May 17, 2021	BUY	$2.73 - $4.5 $641,629 - $1.06 Million	235,029 Added 53.58%	673,688 $2.31 Million
Q4 2020 Feb 16, 2021	BUY	$2.6 - $3.32 $113,815 - $145,333	43,775 Added 11.09%	438,659 $1.16 Million
Q3 2020 Nov 16, 2020	SELL	$2.46 - $4.27 $29,726 - $51,598	-12,084 Reduced 2.97%	394,884 $1.23 Million
Q2 2020 Aug 14, 2020	BUY	$1.45 - $4.3 $521,592 - $1.55 Million	359,719 Added 761.33%	406,968 $1.68 Million
Q1 2020 May 15, 2020	BUY	$0.75 - $2.55 $107 - $364	143 Added 0.3%	47,249 $76,000
Q4 2019 Feb 14, 2020	SELL	$1.65 - $2.48 $13,328 - $20,033	-8,078 Reduced 14.64%	47,106 $117,000
Q3 2019 Nov 14, 2019	SELL	$1.48 - $2.52 $109,998 - $187,293	-74,323 Reduced 57.39%	55,184 $93,000
Q2 2019 Aug 14, 2019	SELL	$2.45 - $3.32 $51,467 - $69,743	-21,007 Reduced 13.96%	129,507 $324,000
Q1 2019 May 15, 2019	SELL	$2.52 - $3.24 $286,667 - $368,572	-113,757 Reduced 43.05%	150,514 $462,000
Q4 2018 Feb 14, 2019	BUY	$1.92 - $4.1 $126,044 - $269,156	65,648 Added 33.05%	264,271 $698,000
Q3 2018 Nov 14, 2018	BUY	$3.39 - $4.61 $673,331 - $915,652	198,623 New	198,623 $856,000
Q2 2018 Aug 14, 2018	BUY	$1.89 - $4.95 $173,862 - $455,355	91,991 New	91,991 $362,000
Q4 2017 Feb 14, 2018	SELL	$1.91 - $2.83 $167,283 - $247,859	-87,583 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$2.44 - $2.91 $213,702 - $254,866	87,583	87,583 $235,000

Others Institutions Holding MEIP

# of Institutions

Shares Held

Call Options Held

Put Options Held

Urban Wealth Management, LLC

2K
Shares

$5,557
0.0% of portfolio

View Full List

About MEI Pharma, Inc.

Ticker MEIP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 133,261,000
Market Cap $370M
Description
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...

More about MEIP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account